Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
Western Pacific
Clear all
Type of publications
NITAG documentation
(122)
Reports
(1)
Scientific publications
(6)
Systematic reviews (SYSVAC)
(71)
Topics
Agenda & Minutes
(47)
Background paper
(1)
Functioning
(16)
Recommendation
(51)
Regions
Western Pacific
(122)
Africa
(132)
Americas
(601)
Eastern Mediterranean
(18)
Europe
(563)
South-East Asia
(37)
Countries
Australia
(89)
China
(15)
Mongolia
(1)
New Zealand
(10)
South Korea
(7)
Diseases
COVID-19
(29)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(13)
Influenza
(13)
Japanese encephalitis
(1)
Meningococcal disease
(5)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(3)
Tuberculosis
(1)
Publication date
2023
(6)
2022
(13)
2021
(13)
2020
(5)
2019
(6)
2018
(3)
2017
(5)
2016
(6)
2015
(7)
2014
(6)
2013
(9)
2012
(3)
2011
(6)
2010
(20)
2009
(6)
2008
(7)
2007
(1)
Target population
Adults
(1)
Children
(1)
Older adults
(1)
Available to download in languages
English (EN)
(97)
Russian (RU)
(1)
122 results found
2023
∙
ATAGI
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
2023
∙
ATAGI
ATAGI Update on the COVID-19 Vaccination Program
2023
∙
ATAGI
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
2023
∙
ATAGI
ATAGI advice on seasonal influenza vaccines in 2023
2023
∙
ATAGI
ATAGI 2023 booster advice
2023
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
2022
∙
ATAGI
ATAGI statement on the intradermal use of Imojev Japanese encephalitis vaccine
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register